Diltiazem Hydrochloride Tablets 30mg (Herbesser® / ヘルベッサー錠30)

JPY ¥1,500

Japanese Calcium Channel Blocker (Diltiazem Hydrochloride 30mg). Oral tablet for angina pectoris and essential hypertension. 100 tablets [10 tablets (PTP) x 10]. Mfd. by Tanabe Pharma Corporation, Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥1,380
10 - 19 12% JPY ¥1,320
20 + 18% JPY ¥1,230
SKU: HRB-30-TAB Category:

Description

Product Overview / 商品概要

Herbesser Tablets 30mg (ヘルベッサー錠30)
Generic: Diltiazem Hydrochloride / ジルチアゼム塩酸塩
Therapeutic Category: Calcium Channel Blocker, Diltiazem Hydrochloride Preparation / Ca拮抗剤 ジルチアゼム塩酸塩製剤
Manufactured by: Tanabe Pharma Corporation / 田辺ファーマ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Diltiazem Hydrochloride (JP) 30mg per tablet / 1錠中 日局 ジルチアゼム塩酸塩 30mg
Additives: Hydrogenated oil, Magnesium stearate, Lactose hydrate, Macrogol 6000 / 硬化油、ステアリン酸マグネシウム、乳糖水和物、マクロゴール6000
Appearance: White, uncoated tablet (sustained-release tablet), identification code: TA120, diameter 8.0mm, thickness 3.5mm, weight 0.19g
外観: 白色・素錠(徐放錠)、識別コード: TA120、直径8.0mm、厚さ3.5mm、重量0.19g

Indications / 効能効果

EN: Angina pectoris, Variant angina pectoris, Essential hypertension (mild to moderate)
JA: 狭心症、異型狭心症、本態性高血圧症(軽症~中等症)

Dosage and Administration / 用法用量

EN: Usually, adults are administered 30mg of diltiazem hydrochloride orally three times daily. If the effect is insufficient, the dose may be increased up to 60mg three times daily. Usually, adults are administered 30 to 60mg of diltiazem hydrochloride orally three times daily. The dose may be adjusted according to age and symptoms.
JA: 〈狭心症、異型狭心症〉通常、成人にはジルチアゼム塩酸塩として1回30mgを1日3回経口投与する。効果不十分な場合には、1回60mgを1日3回まで増量することができる。〈本態性高血圧症(軽症~中等症)〉通常、成人にはジルチアゼム塩酸塩として1回30~60mgを1日3回経口投与する。なお、年齢、症状により適宜増減する。

Contraindications / 禁忌

EN: Patients with severe congestive heart failure; patients with second-degree or higher atrioventricular block or sick sinus syndrome; patients with a history of hypersensitivity to any component of this product; pregnant women or women who may be pregnant; patients receiving asunaprevir-containing preparations, ivabradine hydrochloride, or lomitapide mesilate
JA: 重篤なうっ血性心不全の患者、2度以上の房室ブロック・洞不全症候群のある患者、本剤の成分に対し過敏症の既往歴のある患者、妊婦又は妊娠している可能性のある女性、アスナプレビルを含有する製剤・イバブラジン塩酸塩・ロミタピドメシル酸塩を投与中の患者

Regulatory Information / 規制情報

Approval No.: 21700AMZ00195
Sales Started: February 1974 / 1974年2月
Classification Code: 872171
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Diltiazem Hydrochloride Tablets 30mg (Herbesser® / ヘルベッサー錠30)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Diltiazem Hydrochloride Tablets 30mg (Herbesser®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.